Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro

Oncogene

Volumn 26, Issue 34, 2007, Pages 4961-4968

  He, X ^a   Pool, M ^b   Darcy, K M ^c   Lim, S B ^a   Auersperg, N ^d   Coon, J S ^b   Beck, W T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Buffalo Niagara Enterprise   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Epithelial ovarian cancer; Polypyrimidine tract binding protein; RNA interference; Tissue microarray; Tumorigenesis

Indexed keywords

DOXYCYCLINE; POLYPYRIMIDINE TRACT BINDING PROTEIN; SMALL INTERFERING RNA; T LYMPHOCYTE ANTIGEN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL IMMORTALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM TUMOR; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; KNOCKOUT GENE; OVARY TUMOR; PRIORITY JOURNAL; SIMIAN VIRUS 40; TISSUE MICROARRAY; TUMOR CELL; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; RNA INTERFERENCE; TISSUE ARRAY ANALYSIS;

EID: 34547489950     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210307     Document Type: Article

References (32)

1. Bast Jr RC, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J et al. (2005). Translational crossroads for biomarkers. Clin Cancer Res 11: 6103-6108.
2. Black DL. (2003). Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
3. Bryan TM, Reddel RR. (1994). SV40-induced immortalization of human cells. Crit Rev Oncogene 5: 331-357.
4. Bushell M, Stoneley M, Kong YW, Hamilton TL, Spriggs KA, Dobbyn HC et al. (2006). Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell 23: 401-412.
5. Castelo-Branco P, Furger A, Wollerton M, Smith C, Moreira A, Proudfoot N. (2004). Polypyrimidine tract binding protein modulates efficiency of polyadenylation. Mol Cell Biol 24: 4174-4183.
6. Cornelis S, Tinton SA, Schepens B, Bruynooghe Y, Beyaert R. (2005). UNR translation can be driven by an IRES element that is negatively regulated by polypyrimidine tract binding protein. Nucleic Acids Res 33: 3095-3108.
7. Cote CA, Gautreau D, Denegre JM, Kress TL, Terry NA, Mowry KL. (1999). A Xenopus protein related to hnRNP I has a role in cytoplasmic RNA localization. Mol Cell 4: 431-437.
8. Faustino NA, Cooper TA. (2003). Pre-mRNA splicing and human disease. Genes Dev 17: 419-437.
9. Garcia-Blanco MA, Jamison SF, Sharp PA. (1989). Identification and purification of a 62 000-dalton protein that binds specifically to the polypyrimidine tract of introns. Genes Dev 3: 1874-1886.
10. He X, Ee PL, Coon JS, Beck WT. (2004). Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin Cancer Res 10: 4652-4660.
11. Huang S, Deerinck TJ, Ellisman MH, Spector DL. (1997). The dynamic organization of the perinucleolar compartment in the cell nucleus. J Cell Biol 137: 965-974.
12. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. (2003). Cancer statistics, 2003. CA Cancer J Clin 53: 5-26.
13. Jin W, Bruno IG, Xie TX, Sanger LJ, Cote GJ. (2003). Polypyrimidine tract-binding protein down-regulates fibroblast growth factor receptor 1 alpha-exon inclusion. Cancer Res 63: 6154-6157.
14. Jin W, McCutcheon IE, Fuller GN, Huang ES, Cote GJ. (2000). Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res 60: 1221-1224.
15. Jin X, Burke W, Rothman K, Lin J. (2002). Resistance to p53-mediated growth suppression in human ovarian cancer cells retain endogenous wild-type p53. Anticancer Res 22: 659-664.
16. Kamath RV, Thor AD, Wang C, Edgerton SM, Slusarczyk A, Leary DJ et al. (2005). Perinucleolar compartment prevalence has an independent prognostic value for breast cancer. Cancer Res 65: 246-253.
17. Kasper JS, Kuwabara H, Arai T, Ali SH, DeCaprio JA. (2005). Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J Virol 79: 11685-11692.
18. Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkruger A, Verkade P et al. (2004). Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 6: 207-214.
19. Kosinski PA, Laughlin J, Singh K, Covey LR. (2003). A complex containing polypyrimidine tract-binding protein is involved in regulating the stability of CD40 ligand (CD154) mRNA. J Immunol 170: 979-988.
20. Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A et al. (2004). A genetically defined model for human ovarian cancer. Cancer Res 64: 1655-1663.
21. Maines-Bandiera SL, Kruk PA, Auersperg N. (1992). Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 167: 729-735.
22. Matera AG, Frey MR, Margelot K, Wolin SL. (1995). A perinucleolar compartment contains several RNA polymerase III transcripts as well as the polypyrimidine tract-binding protein, hnRNP I. J Cell Biol 129: 1181-1193.
23. Mitchell SA, Brown EC, Coldwell MJ, Jackson RJ, Willis AE. (2001). Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Mol Cell Biol 21: 3364-3374.
24. Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ et al. (2004). Focus on epithelial ovarian cancer. Cancer Cell 5: 19-24.
25. Venables JP. (2004). Aberrant and alternative splicing in cancer. Cancer Res 64: 7647-7654.
26. Wagner EJ, Garcia-Blanco MA. (2001). Polypyrimidine tract binding protein antagonizes exon definition. Mol Cell Biol 21: 3281-3288.
27. Wang J, Pederson T. (1990). A 62 000 molecular weight spliceosome protein crosslinks to the intron polypyrimidine tract. Nucleic Acids Res 18: 5995-6001.
28. Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH et al. (2003). Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res 63: 655-657.
29. Wiznerowicz M, Trono D. (2003). Conditional suppression of cellular gene: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77: 8957-8961.
30. Wollerton MC, Gooding C, Wagner EJ, Garcia-Blanco MA, Smith CW. (2004). Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol Cell 13: 91-100.
31. Xu Q, Lee C. (2003). Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 31: 5635-5643.
32. Zang WQ, Li B, Huang PY, Lai MM, Yen TS. (2001). Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element. J Virol 75: 10779-10786.